References
- Bachmann MF, van Damme P, Lienert F, Schwarz TF. Viruslike particles: a versatile and effective vaccine platform. Expert Rev Vaccines. 2025 May; 24(1):444-456. https://doi.org/10.1080/14760584.2025.2508517
- Beckett D, Kovaleva E, Schatz PJ. A minimal peptide substrate in biotin holoenzyme synthetasecatalyzed biotinylation. Protein Sci. 1999 Apr; 8(4):921-929. https://doi.org/10.1110/ps.8.4.921
- BerreirosHortala H, VilchezPinto G, DiazPerales A, Garrido-Arandia M, TomeAmat J. Viruslike Particles as Vaccines for AllergenSpecific Therapy: An Overview of Current Developments. Int J Mol Sci. 2024 Jul; 25(13):7429. https://doi.org/10.3390/ijms25137429 MDPI
- Biela AP, Naskalska A, Fatehi F, Twarock R, Heddle JG. Programmable polymorphism of a virus-like particle. Commun Mater. 2022 Feb; 3:7. https://doi.org/10.1038/s43246-022-00229-3
- Brune KD, Howarth M. New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue. Front Immunol. 2018 Jun; 9:1432. https://doi.org/10.3389/fim-mu.2018.01432
- Bruun TUJ, Andersson AC, Draper SJ, Howarth M. Engineering a Rugged Nanoscaffold To Enhance PlugandDisplay Vaccination. ACS Nano. 2018 Sep; 12(9):8855-8866. https://doi.org/10.1021/acsnano.8b02805
- Castón JR, Luque D. Conventional Electron Microscopy, Cryogenic Electron Microscopy, and Cryogenic Electron Tomography of Viruses. Subcell Biochem. 2024 Dec; 105:81-134. https://doi.org/10.1007/978-3-031-65187-8_3
- Charlton Hume HK, Vidigal J, Carrondo MJT, Middelberg APJ, Roldão A, Lua LHL. Synthetic biology for bioengineering viruslike particle vaccines. Biotechnol Bioeng. 2019 Apr; 116(4):919-935. https://doi.org/10.1002/bit.26920
- Chiba S, Frey SJ, Halfmann PJ, Kuroda M, Maemura T, Yang JE, Wright ER, Kawaoka Y, Kane RS. Multivalent nanoparticlebased vaccines protect hamsters against SARSCoV-2 after a single immunization. Commun Biol. 2021 May; 4(1):597. https://doi.org/10.1038/s42003-021-02128-8
- Chung YH, Volckaert BA, Steinmetz NF. Development of a Modular NTA:His Tag Viral Vaccine for Codelivery of Antigen and Adjuvant. Bioconjug Chem. 2023 Jan; 34(1):269-278. https://doi.org/10.1021/acs.bioconjchem.2c00601
- Dowling QM, Park YJ, Fries CN, Gerstenmaier NC, Ols S, Yang EC, Wargacki AJ, Dosey A, Hsia Y, Ravichandran R, Walkey CD, Burrell AL, Veesler D, Baker D, King NP. Hierarchical design of pseudosymmetric protein nanocages. Nature. 2024 Dec; 638(8050):553-561. https://doi.org/10.1038/s41586-024-08360-6
- Fowler A, Van Rompay KKA, Sampson M, Leo J, Watanabe JK, Usachenko JL, Immareddy R, Lovato DM, Schiller JT, Remaley AT, Chackerian B. A viruslike particlebased bivalent PCSK9 vaccine lowers LDLcholesterol levels in nonhuman primates. NPJ Vaccines. 2023 Sep; 8(1):142. https://doi.org/10.1038/s41541-023-00743-6
- Freund C, Schwarzer D. Engineered Sortases in Peptide and Protein Chemistry. ChemBioChem. 2021 Feb 3; 22(8): 1347-1356. https://doi.org/10.1002/cbic.202000745
- Galinier R, Gout E, LortatJacob H, Wood J, Chroboczek J. Adenovirus protein involved in virus internalization recruits ubiquit-inprotein ligases. Biochemistry. 2002 Dec; 41(48): 14299-14305. https://doi.org/10.1021/bi020125b
- Goksøyr L, Skrzypczak M, Sampson M, Nielsen MA, Salanti A, Theander TG, Remaley AT, De Jongh WA, Sander AF. A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines. Vaccines (Basel). 2022 Dec; 11(1):2. https://doi.org/10.3390/vaccines11010002
- Graham M, Zhang P. Cryoelectron tomography to study viral infection. Biochem Soc Trans. 2023 Aug; 51(4):1701-1711. https://doi.org/10.1042/BST20230103
- Grgacic EV, Anderson DA. Viruslike particles: passport to immune recognition. Methods. 2006 Sep; 40(1):60-65. https://doi.org/10.1016/j.ymeth.2006.07.018
- Hagge LM, Shahrivarkevishahi A, AlKharji NM, Chen Z, Brohlin OR, Trashi I, Tumac A, C Herbert F, Adlooru AV, Lee H, Firouzi HR, Cornelius SA, De Nisco NJ, Gassensmith JJ. Intracellular delivery of viruslike particles using a sheddable linker. J Mater Chem B. 2023 Jun; 11(30):7126-7133. https://doi.org/10.1039/D3TB00696D
- Halfmann PJ, Loeffler K, Duffy A, Kuroda M, Yang JE, Wright ER, Kawaoka Y, Kane RS. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spikeproteinnanoparticle vaccine. Nat Commun. 2024 Feb; 15(1):1284. https://doi.org/10.1038/s41467-024-45495-6
- He B, Wilson B, Chen SH, Sharma K, Scappini E, Cook M, Petrovich R, Martin NP. Molecular Engineering of Virus Tropism. Int J Mol Sci. 2024 Oct; 25(20): 11094. https://doi.org/10.3390/ijms252011094
- He J, Yu L, Lin X, Liu X, Zhang Y, Yang F, Deng W. Viruslike Particles as Nanocarriers for Intracellular Delivery of Biomolecules and Compounds. Viruses. 2022 Aug; 14(9):1905. https://doi.org/10.3390/v14091905
- Heddle JG, Chakraborti S, Iwasaki K. Natural and artificial protein cages: design, structure and therapeutic applications. Curr Opin Struct Biol. 2017 Mar; 43:148-155. https://doi.otg/10.1016Zj. sbi.2017.03.007
- Ikwuagwu B, TullmanErcek D. Viruslike particles for drug delivery: a review of methods and applications. Curr Opin Biotechnol. 2022 Dec; 78:102785. https://doi.org/10.1016/j.copbio.2022.102785
- Ingham RJ, Gish G, Pawson T. The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture. Oncogene. 2004 May; 23(11):1972-1984. https://doi.org/10.1038/sj.onc.1207436
- Jagadish MN, Edwards SJ, Hayden MB, Grusovin J, Vandenberg K, Schoofs P, Hamilton RC, Shukla DD, Kalnins H, McNamara M, Haynes J, Nisbet IT, Ward CW, Pye D. Chimeric potyvirus-like particles as vaccine carriers. Intervirology. 1996; 39(12):85-92. https://doi.org/10.1159/000150479
- Janitzek CM, Peabody J, Thrane S, Carlsen PHR, Theander TG, Salanti A, Chackerian B, Nielsen MA, Sander AF. A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine. Sci Rep. 2019 Mar; 9(1):5260. https://doi.org/10.1038/s41598-019-41768-2
- King LDW, Pulido D, Barrett JR, Davies H, Quinkert D, Lias AM, Silk SE, Pattinson DJ, Diouf A, Williams BG, McHugh K, & Draper SJ. Preclinical development of a stabilized RH5 viruslike particle vaccine that induces improved antimalarial antibodies. Cell Rep Med. 2024 Jul; 5(7):101654. https://doi.org/10.1016/j. xcrm.2024.101654
- Knappe GA, Wamhoff EC, Read BJ, Irvine DJ, Bathe M. Covalent Functionalization of DNA Origami Viruslike Particles. ACS Nano. 2021 Sep; 15(9):14316-14322. https://doi.org/10.1021/acsna-no.1c03158
- Koho T, Ihalainen TO, Stark M, UusiKerttula H, Wieneke R, Rahikainen R, Blazevic V, Marjomäki V, Tampé R, Kulomaa MS, Hytönen VP. Histagged norovirus-like particles: A versatile platform for cellular delivery and surface display. Eur J Pharm Biopharm. 2015 Jul; 96(1):22-31. https://doi.org/10.1016/j.ejpb.2015.07.002
- Kopatz I, Zalk R, LeviKalisman Y, ZlotkinRivkin E, Frank GA, Kler S. Packaging of DNA origami in viral capsids. Nanoscale. 2019; 11(21):10160-10166. https://doi.org/10.1039/D2NR01316A
- Laitinen OH, Hytönen VP, Nordlund HR, Kulomaa MS. Genetically engineered avidins and streptavidins. Cell Mol Life Sci. 2006 Nov; 63(24):2992-3017. https://doi.org/10.1007/s00018-006-6288-z
- Lee S, Kibler RD, Ahn G, Hsia Y, Borst AJ, Philomin A, Kennedy MA, Huang B, Stoddard B, Baker D. Fourcomponent protein nanocages designed by programmed symmetry breaking. Nature. 2025 Feb; 638(8050):546-552. https://doi.org/10.1038/s41586-024-07814-1
- Leneghan DB, Miura K, Taylor IJ, Li Y, Jin J, Brune KD, Bachmann MF, Howarth M, Long CA, Biswas S. Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines. Sci Rep. 2017 Jun; 7(1):3811. https://doi.org/10.1038/s41598-017-03798-3
- Li X, Pan C, Sun P, Peng Z, Feng E, Wu J, Wang H, Zhu L. Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection. Nano Res. 2022 Feb; 15(2):1645-1653. https://doi.org/10.1007/s12274-021-4045-9
- Liu J, Guo Z, Li W, Zhang X, Liang C, Cui Z. Packaging Quantum Dots in Viral Particles via a Streptag II/Streptavidin System for SingleVirus Tracking. Nano Lett. 2024 Sep; 24(9):2821-2830. https://doi.org/10.1021/acs.nanolett.3c04570
- Luxembourg A, Brown D, Bouchard C, Giuliano AR, Iversen OE, Joura EA, Penny ME, Restrepo JA, Romaguera J, Maansson R, Moeller E, Ritter M, Chen J. Phase II studies to select the formulation of a multivalent HPV L1 viruslike particle (VLP) vaccine. Hum Vaccin Immunother. 2015 Apr; 11(6):1313-1322. https://doi.org/10.1080/21645515.2015.1012010
- Maginnis MS. VirusReceptor Interactions: The Key to Cellular Invasion. J Mol Biol. 2018 Oct; 430(17):2590-2611. https://doi.org/10.1016/j.jmb.2018.07.002
- Mao H, Hart SA, Schink A, Pollok BA. Sortase-mediated protein ligation: a new method for protein engineering. J Am Chem Soc. 2004 Mar; 126(9):2670-2671. https://doi.org/10.1021/ja0392070
- Marini A, Zhou Y, Li Y, Taylor IJ, Leneghan DB, Jin J, Zaric M, Mekhaiel D, Long CA, Miura K, Biswas S. A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response. Front Immunol. 2019 Nov; 10:2931. https://doi.org/10.3389/fimmu.2019.02931
- McFall-Boegeman H, Huang X. Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines. Expert Rev Vaccines. 2022 Apr; 21(4):453-469. https://doi.org/10.1080/1 4760584.2022.2047121
- Mohsen MO, Bachmann MF. Virus-like particle vaccinology, from bench to bedside. Cell Mol Immunol. 2022 Sep; 19(9):993-1011. https://doi.org/10.1038/s41423-022-00904-4
- Mohsen MO, Speiser DE, Michaux J, Pak H, Stevenson BJ, Vogel M, Inchakalody VP, de Brot S, Dermime S, Coukos G, BassaniSternberg M, Bachmann MF. Bedside formulation of a personalized multineoantigen vaccine against mammary carcinoma. J Immunother Cancer. 2022 Jan; 10(1):e002927. https://doi.org/10.1136/jitc-2021-002927
- Muthuraman KR, Utomo DIS, Matsuda M, Suzuki R, Park EY. Expression of dengue capsidlike particles in silkworm and display of envelope domain III of dengue virus serotype 2. Protein Expr Purif. 2024; 222:106543. https://doi.org/10.1016/j.pep.2024.106543
- Naskalska A, Pyrć K. Virus Like Particles as Immunogens and Universal Nanocarriers. Pol J Microbiol. 2015 Mar; 64(1):3-13. https://doi.org/10.33073/pjm-2015-001
- Naskalska A, Szolajska E, Andreev I, Podsiadla M, Chroboczek J. Towards a novel influenza vaccine: engineering of hemagglutinin on a platform of adenovirus dodecahedron. BMC Biotechnol. 2013 Jul; 13:50. https://doi.org/10.1186/1472-6750-13-50
- Naskalska A, Szolajska E, Chaperot L, Angel J, Plumas J, Chroboczek J. Influenza recombinant vaccine: matrix protein M1 on the platform of the adenovirus dodecahedron. Vaccine. 2009 Dec; 27(52):7385-7393. https://doi.org/10.1016/j.vaccine.2009.09.022
- Nooraei S, Bahrulolum H, Hoseini ZS, Katalani C, Hajizade A, Easton AJ, Ahmadian G. Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. J Nanobiotechnology. 2021 Mar; 19(1):59. https://doi.org/10.1186/s12951-021-00806-7
- Panasiuk M, Chraniuk M, Zimmer K, Hovhannisyan L, Krapchev V, PeszyńskaSularz G, Narajczyk M, Węsławski J, Konopacka A, Gromadzka B. Characterization of surface-exposed structural loops as insertion sites for foreign antigen delivery in calicivirus-derived VLP platform. Front Microbiol. 2023 Aug; 14:1111947. https://doi.org/10.3389/fmicb.2023.1111947
- Patterson D, Schwarz B, Avera J, Western B, Hicks M, Krugler P, Terra M, Uchida M, McCoy K, Douglas T. Sortase-Mediated Ligation as a Modular Approach for the Covalent Attachment of Proteins to the Exterior of the Bacteriophage P22 Virus-like Particle. Bioconjug Chem. 2017 Aug; 28(8):2114-2124. https://doi.org/10.1021/acs.bioconjchem.7b00308
- Pereboeva L, Komarova S, Roth J, Ponnazhagan S, Curiel DT. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus. Gene Ther. 2007 Aug; 14(8):627-637. https://doi.org/10.1038/sj.gt.3302922
- Perler FB. Protein splicing mechanisms and applications. IUBMB Life. 2005 Jul; 57(7):469-476. https://doi.org/10.1080/15216540500239945
- Petty KJ. Metal-chelate affinity chromatography. Curr Protoc Mol Biol. 2001; Chapter 10:Unit 10.11B. https://doi.org/10.1002/0471142727.mb1011bs57
- Pillai A, Idris A, Philomin A, Weidle C, Skotheim R, Leung PJY, Broerman A, Demakis C, Borst AJ, Praetorius F, Baker D. De novo design of allosterically switchable protein assemblies. Nature. 2024 Oct; 632(8026):911-920. https://doi.org/10.1038/s41586-024-05447-4
- Pokorski JK, Hovlid ML, Finn MG. Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor. Chem biochem. 2011 Aug; 12(16):2441-2447. https://doi.org/10.1002/cbic.201100309
- Rahikainen R, Rijal P, Tan TK, Wu HJ, Andersson AC, Barrett JR, Bowden TA, Draper SJ, Townsend AR, Howarth M. Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation. Angew Chem Int Ed. 2021 Jan; 133(1):325-334. https://doi.org/10.1002/ange.202012676
- Riedmiller I, Fougeroux C, Jensen RW, Kana IH, Sander AF, Theander TG, Lavstsen T, Turner L. Mosaic and cocktail capsid-virus-like particle vaccines for induction of antibodies against the EPCR-binding CIDRα1 domain of PfEMP1. PLoS One. 2024 Jul; 19(7):e0302243. https://doi.org/10.1371/journal.pone.0302243
- Rohovie MJ, Nagasawa M, Swartz JR. Virus-like particles: Next-generation nanoparticles for targeted therapeutic delivery. Bioeng Transl Med. 2017 Jan; 2(1):43-57. https://doi.org/10.1002/btm2.10049
- Seitz I, Saarinen S, Kumpula EP, McNeale D, Anaya-Plaza E, Lampinen V, Hytönen VP, Sainsbury F, Cornelissen JJLM, Linko V, Huiskonen JT, Kostiainen MA. DNA-origami-directed virus capsid polymorphism. Nat Nanotechnol. 2023 Oct; 18(10):1205-1212. https://doi.org/10.1038/s41565-023-01469-6
- Seitz I, Saarinen S, Wierzchowiecka J, Kumpula EP, Shen B, Cornelissen JJLM, Linko V, Huiskonen JT, Kostiainen MA. Folding of mRNA-DNA Origami for Controlled Translation and Viral Vector Packaging. Adv Mater. 2025 Apr; 37(15):e2417642. https://doi.org/10.1002/adma.202417642
- Sharma J, Uchida M, Miettinen HM, Douglas T. Modular interior loading and exterior decoration of a virus-like particle. Nanoscale. 2017 Jul; 9(29):10420-10430. https://doi.org/10.1039/c7nr02367d
- Shepley-McTaggart A, Fan H, Sudol M, Harty RN. Viruses go modular. J Biol Chem. 2020 Apr; 295(14):4604-4616. https://doi.org/10.1074/jbc.REV120.011760
- Smith ML, Lindbo JA, Dillard-Telm S, Brosio PM, Lasnik AB, McCormick AA, Nguyen LV, Palmer KE. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications. Virology. 2006 Sep; 348(2):475-488. https://doi.org/10.1016/j.virol.2006.06.011
- Smith MT, Hawes AK, Bundy BC. Reengineering viruses and virus-like particles through chemical functionalization strategies. Curr Opin Biotechnol. 2013 Aug; 24(4):620-626. https://doi.org/10.1016/j.copbio.2013.03.009
- Strable E, Finn MG. Chemical modification of viruses and virus-like particles. Curr Top Microbiol Immunol. 2009; 327:1-21. https://doi.org/10.1007/978-3-540-92165-3_1
- Su S, Shen X, Shi X, Li X, Chen J, Yang W, Sun M, Tang YD, Wang H, Wang S, Cai X, Lu Y, An T, Yang Y, Meng F. Cell-penetrating peptides TAT and 8R functionalize P22 virus-like particles to enhance tissue distribution and retention. Front Vet Sci. 2024 Apr; 11:1460973. https://doi.org/10.3389/fvets.2024.1460973
- Sun J, DuFort C, Daniel MC, Murali A, Chen C, Gopinath K, Stein B, De M, Rotello VM, Holzenburg A, Kao CC, Dragnea B. Core-controlled polymorphism in virus-like particles. Proc Natl Acad Sci US A. 2007 Jan; 104(4): 1354-1359. https://doi.org/10.1073/pnas.0610052104
- Tang J, Becker M, Lenhoff A, Chen W. Engineering of heterobifunctional biopolymers for tunable binding and precipitation of Strep-Tag proteins and virus-like nanoparticles. Biotechnol Bioeng. 2024 Dec; 121(12):3860-3868. https://doi.org/10.1002/bit.29587
- Tang S, Xuan B, Ye X, Huang Z, Qian Z. A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles. Sci Rep. 2016 May; 6:25741. https://doi.org/10.1038/srep25741
- Thrane S, Janitzek CM, Agerbæk M, Ditlev SB, Resende M, Nielsen MA, Theander TG, Salanti A, Sander AF. A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA. PLoS One. 2015 Nov; 10(11):e0143071. https://doi.org/10.1371/journal.pone.0143071
- Viscidi RP, Rowley T, Bossis I. Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming. Int J Mol Sci. 2023 Jun; 24(12). https://doi.org/10.3390/ijms24121456
- Voss S, Skerra A. Mutagenesis of a flexible loop in streptavidin leads to higher affinity for the Strep-tag II peptide and improved performance in recombinant protein purification. Protein Eng. 1997 Aug; 10(8):975-982. https://doi.org/10.1093/protein/10.8.975
- Wang Z, Tang S, Yue N, Qian Z, Zhou S. Development of HBc virus-like particles as modular nanocarrier by intein-mediated trans-splicing. Biochem Biophys Res Commun. 2021 Dec; 534:891895. https://doi.org/10.1016/j.bbrc.2020.12.030
- Watson JL, Juergens D, Bennett NR, Trippe BL, Yim J, Eisenach HE, Ahern W, Borst AJ, Ragotte RJ, & Baker D. De novo design of protein structure and function with RFdiffusion. Nature. 2023 Apr; 620(7976): 1089-1100. https://doi.org/10.1038/s41586-023-06457-8
- Woods MD, Cali M, Ceesay B, Fancher S, Ibrasheva G, Kandeel S, Nassar M, Azghani A, Bill B, Patterson DP. Engineering the HK97 virus-like particle as a nanoplatform for biotechnology applications. J Mater Chem B. 2023 Jul; 11(26):6060-6074. https://doi.org/10.1039/d3tb01065k
- Yang MH, Hu CC, Wong CH, Liang JJ, Ko HY, He MH, Lin YL, Lin NS, Hsu YH. Convenient Auto-Processing Vector Based on Bamboo Mosaic Virus for Presentation of Antigens Through Enzymatic Coupling. Front Immunol. 2021 Aug; 12:739837. https://doi.org/10.3389/fimmu.2021.739837
- Yasuda J, Nakao M, Kawaoka Y, Shida H. Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol. 2003 Sep; 77(18):9987-9992. https://doi.org/10.1128/jvi.77.18.9987-9992.2003
- Yin Z, Comellas-Aragones M, Chowdhury S, Bentley P, Kaczanowska K, Benmohamed L, Gildersleeve JC, Finn MG, Huang X. Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids. ACS Chem Biol. 2013 Jun; 8(6):1253-1262. https://doi.org/10.1021/cb400126q
- Yur D, Sullivan MO, Chen W. Highly modular hepatitis B virus-like nanocarriers for therapeutic protein encapsulation and targeted delivery to triple negative breast cancer cells. J Mater Chem B. 2023 May; 11(18):3985-3993. https://doi.org/10.1039/d3tb00456a
- Zakeri B, Fierer JO, Celik E, Chittock EC, Schwarz-Linek U, Moy VT, Howarth M. Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc Natl Acad Sci U S A. 2012 Mar; 109(12):E690-E697. https://doi.org/10.1073/pnas.1115485109
- Zdanowicz M, Chroboczek J. Virus-like particles as drug delivery vectors. Acta Biochim Pol. 2016 Jul; 63(3):469-473. https://doi.org/10.18388/abp.2015_1149